A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy

BACKGROUND: In this study we aimed to identify a prognostic signature in BRCA1/2 mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gynecologic cancer in women worldwide. METHODS: Univariate Cox proportional-haz...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yinglian, Jia, Li Ping, Liu, Yuzhu, Han, Yiyu, Li, Qian, Zou, Qin, Zhang, Zhongpei, Huang, Jin, Deng, Qingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502206/
https://www.ncbi.nlm.nih.gov/pubmed/32950050
http://dx.doi.org/10.1186/s13048-020-00712-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502206/
https://www.ncbi.nlm.nih.gov/pubmed/32950050
http://dx.doi.org/10.1186/s13048-020-00712-w

Ejemplares similares